Persistence of long-term COVID-19 sequelae in patients with cancer: An analysis from the OnCovid registry.

ABSTRACT:

Introduction

A significant proportion of patients with cancer who recover from Coronavirus Disease 2019 (COVID-19) may experience COVID-19 sequelae in the early post-infection phase, which negatively affect their continuity of care and oncological outcome. The long-term prevalence and clinical impact of the post-COVID-19 syndrome in patients with cancer are largely unknown.

Methods

In this study, we describe the time course of COVID-19 sequelae in patients with non-advanced cancers enrolled in the OnCovid registry.

Results

Overall, 186 patients were included, with a median observation period of 9.9 months (95%CI:8,8-11.3) post-COVID-19 resolution. After a median interval of 2.3 months post-COVID-19 (interquartile range: 1.4-3.7), 31 patients (16.6%) reported ≥1 sequel

SUBMITTER: Cortellini A 

PROVIDER: S-EPMC9040509 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature